Researchers document traumatic brain injury as a global health problem that affects 55 million people worldwide and is the leading cause of injury-related death and disability.
NG2-glia, a newly discovered type of brain cell that can renew itself is regulated by circadian rhythms. The findings shed new light on how the body's circadian clock can promote healing following a traumatic brain injury.
The levels of two protein biomarkers, GFAP and UCH-L1 found in blood samples taken 24 hours after a traumatic brain injury can help to predict which patients will die and which will obtain a severe disability.
Researchers identified a unique biomarker associated with only the chronic or acute stage of traumatic brain injury.
In children, traumatic brain injury can lead to reduced brain size and cognitive impairments that affect learning, researchers report.
A new mouse study identifies a targeted delivery method system that boosts the number of specialized anti-inflammatory immune cells within the brain to areas restricted by brain inflammation and damage. The system helped to protect against apoptosis associated with brain injury, stroke, and multiple sclerosis.
A preclinical drug that inhibits the kinase enzyme Cdk5 may have the potential to treat depression, brain injuries, and disorders associated with cognitive impairment.